These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Jin DY, Chen X, Liu Y, Williams CM, Pedersen LC, Stafford DW, Tie JK. Nat Commun; 2023 Feb 14; 14(1):828. PubMed ID: 36788244 [Abstract] [Full Text] [Related]
35. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F, Kashima T, Kimura S, Kanamori M, Echizen H. Clin Pharmacol Ther; 2000 Nov 14; 68(5):541-55. PubMed ID: 11103757 [Abstract] [Full Text] [Related]
39. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives. Kasperkiewicz K, Ponczek MB, Owczarek J, Guga P, Budzisz E. Molecules; 2020 Mar 24; 25(6):. PubMed ID: 32213944 [Abstract] [Full Text] [Related]
40. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle. Bell RG. Fed Proc; 1978 Oct 24; 37(12):2599-604. PubMed ID: 359368 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]